A significant shift in Canadian drug policy has occurred, as the government allow the availability of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were severely restricted, but a increasing body of studies suggests they may offer aid for mental health conditions like PTSD. This development represents a major step